Skip to main content

Advertisement

Open Peer Review Reports for: Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 May 2014 Submitted Original manuscript
1 May 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 2
1 May 2014 Submitted Manuscript version 2
1 May 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 3
1 May 2014 Submitted Manuscript version 3
29 May 2014 Reviewed Reviewer Report - Brian Gabrielli
29 Jun 2014 Reviewed Reviewer Report - Ratna Vadlamudi
7 Jul 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 4
7 Jul 2014 Submitted Manuscript version 4
16 Jul 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 5
16 Jul 2014 Submitted Manuscript version 5
21 Jul 2014 Author responded Author comments - Andrew Massey
Resubmission - Version 6
21 Jul 2014 Submitted Manuscript version 6
Publishing
28 Jul 2014 Editorially accepted
7 Aug 2014 Article published 10.1186/1471-2407-14-570

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement